Loading…
Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase
We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assay...
Saved in:
Published in: | Journal of medicinal chemistry 2006-07, Vol.49 (14), p.4183-4195 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 4195 |
container_issue | 14 |
container_start_page | 4183 |
container_title | Journal of medicinal chemistry |
container_volume | 49 |
creator | NGUYEN, Corinne RUDA, Gian Filippo SCHIPANI, Alessandro KASINATHAN, Ganasan LEAL, Isabel MUSSO-BUENDIA, Alexander KAISER, Marcel BRUN, Reto RUIZ-PéREZ, Luis M. SAHLBERG, Britt-Louise JOHANSSON, Nils Gunnar GONZáLEZ-PACANOWSKA, Dolores GILBERT, Ian H. |
description | We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assayed against both P.falciparum dUTPase and intact parasites. A good correlation was observed between enzyme inhibition and cellular assays. Acyclic uracil derivatives were identified that showed greater or similar potency and in general increased selectivity compared to previously reported inhibitors. The most active compound reported here against the P. falciparum enzyme had a K(i) of 0.2 microM. Molecular modeling studies provided a good rationale for the observed activities. Preliminary ADME studies indicated that some of the lead compounds are drug-like molecules. These compounds are useful tools for further investigating P. falciparum dUTPase for the development of much-needed novel antimalarial drugs. |
doi_str_mv | 10.1021/jm060126s |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68608803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68608803</sourcerecordid><originalsourceid>FETCH-LOGICAL-i277t-45c465835ca3398dff711bf6e9473bc58e96e8053a70ed6f25b71476e590a6653</originalsourceid><addsrcrecordid>eNpFzztPwzAQAGALgWgpDPwBlAW2wPntjKXiUbWCCtqFJXIcB1ycpMSJRP89kVpgutPdp3sgdI7hGgPBN-sSBGAiwgEaYk4gZgrYIRoCEBITQegAnYSwBgCKCT1GAywUwVKqIZqNzdZ4Z6KnznhbB5fbaFxpX793NkQ6RNPqw2WurZsQ1UW08DqUde66Miq0N26jmz7NV8uFDvYUHfXFYM_2cYRW93fLyWM8f36YTsbz2BEp25hxwwRXlBtNaaLyopAYZ4WwCZM0M1zZRFgFnGoJNhcF4ZnETArLE9BCcDpCV7u5m6b-6s9s09IFY73Xla27kAolQCmgPbzYwy4rbZ5uGlfqZpv-vt-Dyz3QwWhfNLoyLvw7mVAGTPQu3jkXWvv919fNZyoklTxdLl77tXj2Nnu5TYH-AHtydnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68608803</pqid></control><display><type>article</type><title>Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>NGUYEN, Corinne ; RUDA, Gian Filippo ; SCHIPANI, Alessandro ; KASINATHAN, Ganasan ; LEAL, Isabel ; MUSSO-BUENDIA, Alexander ; KAISER, Marcel ; BRUN, Reto ; RUIZ-PéREZ, Luis M. ; SAHLBERG, Britt-Louise ; JOHANSSON, Nils Gunnar ; GONZáLEZ-PACANOWSKA, Dolores ; GILBERT, Ian H.</creator><creatorcontrib>NGUYEN, Corinne ; RUDA, Gian Filippo ; SCHIPANI, Alessandro ; KASINATHAN, Ganasan ; LEAL, Isabel ; MUSSO-BUENDIA, Alexander ; KAISER, Marcel ; BRUN, Reto ; RUIZ-PéREZ, Luis M. ; SAHLBERG, Britt-Louise ; JOHANSSON, Nils Gunnar ; GONZáLEZ-PACANOWSKA, Dolores ; GILBERT, Ian H.</creatorcontrib><description>We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assayed against both P.falciparum dUTPase and intact parasites. A good correlation was observed between enzyme inhibition and cellular assays. Acyclic uracil derivatives were identified that showed greater or similar potency and in general increased selectivity compared to previously reported inhibitors. The most active compound reported here against the P. falciparum enzyme had a K(i) of 0.2 microM. Molecular modeling studies provided a good rationale for the observed activities. Preliminary ADME studies indicated that some of the lead compounds are drug-like molecules. These compounds are useful tools for further investigating P. falciparum dUTPase for the development of much-needed novel antimalarial drugs.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm060126s</identifier><identifier>PMID: 16821778</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimalarials - chemical synthesis ; Antimalarials - pharmacology ; Antiparasitic agents ; Biological and medical sciences ; Erythrocytes - drug effects ; Erythrocytes - parasitology ; Humans ; In Vitro Techniques ; Medical sciences ; Models, Molecular ; Nucleosides - chemical synthesis ; Nucleosides - pharmacology ; Pharmacology. Drug treatments ; Plasmodium falciparum - drug effects ; Plasmodium falciparum - enzymology ; Pyrophosphatases - antagonists & inhibitors ; Pyrophosphatases - chemistry ; Stereoisomerism ; Structure-Activity Relationship ; Trityl Compounds - chemical synthesis ; Trityl Compounds - pharmacology ; Uracil - analogs & derivatives ; Uracil - chemical synthesis ; Uracil - pharmacology</subject><ispartof>Journal of medicinal chemistry, 2006-07, Vol.49 (14), p.4183-4195</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17934046$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16821778$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NGUYEN, Corinne</creatorcontrib><creatorcontrib>RUDA, Gian Filippo</creatorcontrib><creatorcontrib>SCHIPANI, Alessandro</creatorcontrib><creatorcontrib>KASINATHAN, Ganasan</creatorcontrib><creatorcontrib>LEAL, Isabel</creatorcontrib><creatorcontrib>MUSSO-BUENDIA, Alexander</creatorcontrib><creatorcontrib>KAISER, Marcel</creatorcontrib><creatorcontrib>BRUN, Reto</creatorcontrib><creatorcontrib>RUIZ-PéREZ, Luis M.</creatorcontrib><creatorcontrib>SAHLBERG, Britt-Louise</creatorcontrib><creatorcontrib>JOHANSSON, Nils Gunnar</creatorcontrib><creatorcontrib>GONZáLEZ-PACANOWSKA, Dolores</creatorcontrib><creatorcontrib>GILBERT, Ian H.</creatorcontrib><title>Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assayed against both P.falciparum dUTPase and intact parasites. A good correlation was observed between enzyme inhibition and cellular assays. Acyclic uracil derivatives were identified that showed greater or similar potency and in general increased selectivity compared to previously reported inhibitors. The most active compound reported here against the P. falciparum enzyme had a K(i) of 0.2 microM. Molecular modeling studies provided a good rationale for the observed activities. Preliminary ADME studies indicated that some of the lead compounds are drug-like molecules. These compounds are useful tools for further investigating P. falciparum dUTPase for the development of much-needed novel antimalarial drugs.</description><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimalarials - chemical synthesis</subject><subject>Antimalarials - pharmacology</subject><subject>Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Erythrocytes - drug effects</subject><subject>Erythrocytes - parasitology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Nucleosides - chemical synthesis</subject><subject>Nucleosides - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasmodium falciparum - drug effects</subject><subject>Plasmodium falciparum - enzymology</subject><subject>Pyrophosphatases - antagonists & inhibitors</subject><subject>Pyrophosphatases - chemistry</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>Trityl Compounds - chemical synthesis</subject><subject>Trityl Compounds - pharmacology</subject><subject>Uracil - analogs & derivatives</subject><subject>Uracil - chemical synthesis</subject><subject>Uracil - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpFzztPwzAQAGALgWgpDPwBlAW2wPntjKXiUbWCCtqFJXIcB1ycpMSJRP89kVpgutPdp3sgdI7hGgPBN-sSBGAiwgEaYk4gZgrYIRoCEBITQegAnYSwBgCKCT1GAywUwVKqIZqNzdZ4Z6KnznhbB5fbaFxpX793NkQ6RNPqw2WurZsQ1UW08DqUde66Miq0N26jmz7NV8uFDvYUHfXFYM_2cYRW93fLyWM8f36YTsbz2BEp25hxwwRXlBtNaaLyopAYZ4WwCZM0M1zZRFgFnGoJNhcF4ZnETArLE9BCcDpCV7u5m6b-6s9s09IFY73Xla27kAolQCmgPbzYwy4rbZ5uGlfqZpv-vt-Dyz3QwWhfNLoyLvw7mVAGTPQu3jkXWvv919fNZyoklTxdLl77tXj2Nnu5TYH-AHtydnA</recordid><startdate>20060713</startdate><enddate>20060713</enddate><creator>NGUYEN, Corinne</creator><creator>RUDA, Gian Filippo</creator><creator>SCHIPANI, Alessandro</creator><creator>KASINATHAN, Ganasan</creator><creator>LEAL, Isabel</creator><creator>MUSSO-BUENDIA, Alexander</creator><creator>KAISER, Marcel</creator><creator>BRUN, Reto</creator><creator>RUIZ-PéREZ, Luis M.</creator><creator>SAHLBERG, Britt-Louise</creator><creator>JOHANSSON, Nils Gunnar</creator><creator>GONZáLEZ-PACANOWSKA, Dolores</creator><creator>GILBERT, Ian H.</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20060713</creationdate><title>Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase</title><author>NGUYEN, Corinne ; RUDA, Gian Filippo ; SCHIPANI, Alessandro ; KASINATHAN, Ganasan ; LEAL, Isabel ; MUSSO-BUENDIA, Alexander ; KAISER, Marcel ; BRUN, Reto ; RUIZ-PéREZ, Luis M. ; SAHLBERG, Britt-Louise ; JOHANSSON, Nils Gunnar ; GONZáLEZ-PACANOWSKA, Dolores ; GILBERT, Ian H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i277t-45c465835ca3398dff711bf6e9473bc58e96e8053a70ed6f25b71476e590a6653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimalarials - chemical synthesis</topic><topic>Antimalarials - pharmacology</topic><topic>Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Erythrocytes - drug effects</topic><topic>Erythrocytes - parasitology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Nucleosides - chemical synthesis</topic><topic>Nucleosides - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasmodium falciparum - drug effects</topic><topic>Plasmodium falciparum - enzymology</topic><topic>Pyrophosphatases - antagonists & inhibitors</topic><topic>Pyrophosphatases - chemistry</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>Trityl Compounds - chemical synthesis</topic><topic>Trityl Compounds - pharmacology</topic><topic>Uracil - analogs & derivatives</topic><topic>Uracil - chemical synthesis</topic><topic>Uracil - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NGUYEN, Corinne</creatorcontrib><creatorcontrib>RUDA, Gian Filippo</creatorcontrib><creatorcontrib>SCHIPANI, Alessandro</creatorcontrib><creatorcontrib>KASINATHAN, Ganasan</creatorcontrib><creatorcontrib>LEAL, Isabel</creatorcontrib><creatorcontrib>MUSSO-BUENDIA, Alexander</creatorcontrib><creatorcontrib>KAISER, Marcel</creatorcontrib><creatorcontrib>BRUN, Reto</creatorcontrib><creatorcontrib>RUIZ-PéREZ, Luis M.</creatorcontrib><creatorcontrib>SAHLBERG, Britt-Louise</creatorcontrib><creatorcontrib>JOHANSSON, Nils Gunnar</creatorcontrib><creatorcontrib>GONZáLEZ-PACANOWSKA, Dolores</creatorcontrib><creatorcontrib>GILBERT, Ian H.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NGUYEN, Corinne</au><au>RUDA, Gian Filippo</au><au>SCHIPANI, Alessandro</au><au>KASINATHAN, Ganasan</au><au>LEAL, Isabel</au><au>MUSSO-BUENDIA, Alexander</au><au>KAISER, Marcel</au><au>BRUN, Reto</au><au>RUIZ-PéREZ, Luis M.</au><au>SAHLBERG, Britt-Louise</au><au>JOHANSSON, Nils Gunnar</au><au>GONZáLEZ-PACANOWSKA, Dolores</au><au>GILBERT, Ian H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2006-07-13</date><risdate>2006</risdate><volume>49</volume><issue>14</issue><spage>4183</spage><epage>4195</epage><pages>4183-4195</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assayed against both P.falciparum dUTPase and intact parasites. A good correlation was observed between enzyme inhibition and cellular assays. Acyclic uracil derivatives were identified that showed greater or similar potency and in general increased selectivity compared to previously reported inhibitors. The most active compound reported here against the P. falciparum enzyme had a K(i) of 0.2 microM. Molecular modeling studies provided a good rationale for the observed activities. Preliminary ADME studies indicated that some of the lead compounds are drug-like molecules. These compounds are useful tools for further investigating P. falciparum dUTPase for the development of much-needed novel antimalarial drugs.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>16821778</pmid><doi>10.1021/jm060126s</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2006-07, Vol.49 (14), p.4183-4195 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_68608803 |
source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
subjects | Animals Antibiotics. Antiinfectious agents. Antiparasitic agents Antimalarials - chemical synthesis Antimalarials - pharmacology Antiparasitic agents Biological and medical sciences Erythrocytes - drug effects Erythrocytes - parasitology Humans In Vitro Techniques Medical sciences Models, Molecular Nucleosides - chemical synthesis Nucleosides - pharmacology Pharmacology. Drug treatments Plasmodium falciparum - drug effects Plasmodium falciparum - enzymology Pyrophosphatases - antagonists & inhibitors Pyrophosphatases - chemistry Stereoisomerism Structure-Activity Relationship Trityl Compounds - chemical synthesis Trityl Compounds - pharmacology Uracil - analogs & derivatives Uracil - chemical synthesis Uracil - pharmacology |
title | Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A16%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acyclic%20Nucleoside%20Analogues%20as%20Inhibitors%20of%20Plasmodium%20falciparum%20dUTPase&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=NGUYEN,%20Corinne&rft.date=2006-07-13&rft.volume=49&rft.issue=14&rft.spage=4183&rft.epage=4195&rft.pages=4183-4195&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm060126s&rft_dat=%3Cproquest_pubme%3E68608803%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i277t-45c465835ca3398dff711bf6e9473bc58e96e8053a70ed6f25b71476e590a6653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68608803&rft_id=info:pmid/16821778&rfr_iscdi=true |